Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC in Kidney Fibrosis
NCT03460223Phase 2Unknown
- Sponsor
- Nanjing Medical University
- Start
- Apr 2018
- Primary completion
- Mar 2020
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of mesenchymal stem cells in kidney fibrosis, sponsored by Nanjing Medical University. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
kidney fibrosis
Beyond the preview
Go deeper on NCT03460223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03460223.